Should lithium be continued in a patient who still has gambling problems and whose bipolar diagnosis is uncertain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Discontinue Lithium and Reassess the Diagnosis

If lithium has shown no effect on gambling behavior and the bipolar diagnosis is uncertain, lithium should be discontinued. The patient's gambling disorder appears to be the primary clinical problem requiring targeted treatment, not a manifestation of bipolar disorder.

Clinical Reasoning

Lithium's Specific Indication

Lithium is FDA-approved exclusively for bipolar disorder—specifically for treating manic episodes and maintenance therapy to reduce frequency and intensity of manic episodes 1. The drug has no indication for gambling disorder as a primary condition. If the bipolar diagnosis is questionable and lithium has demonstrated no therapeutic benefit, continuing it exposes the patient to unnecessary risks without clinical justification.

Evidence for Lithium in Gambling Disorder

The only scenario where lithium shows efficacy for gambling is when gambling disorder co-occurs with confirmed bipolar spectrum disorder. A 2005 randomized controlled trial found that sustained-release lithium significantly reduced gambling severity in pathological gamblers with bipolar spectrum disorders, with 83% of completers responding versus 29% on placebo 2. Critically, improvement in gambling correlated directly with improvement in mania ratings 2. This means lithium treats the underlying bipolar disorder, which secondarily improves gambling behavior—it does not treat gambling disorder itself.

A 2014 case report similarly demonstrated lithium's effectiveness only in gambling patients with comorbid bipolar spectrum conditions and euphoric temperament 3.

The Diagnostic Imperative

Without a confirmed bipolar diagnosis, lithium has no role. The patient's lack of response suggests either:

  1. No underlying bipolar disorder exists (most likely given your uncertainty)
  2. The gambling is not secondary to mood instability
  3. Lithium is simply ineffective for this individual's bipolar disorder

What Should Happen Next

Immediate steps:

  • Discontinue lithium to avoid unnecessary side effects (tremor, polyuria, weight gain, renal effects) 4
  • Conduct formal diagnostic reassessment for bipolar disorder using DSM-5 criteria
  • Screen for other psychiatric comorbidities common in gambling disorder: depression (30%), anxiety disorders, ADHD, substance use disorders (56% nicotine, 18% alcohol abuse) 5

If bipolar disorder is ruled out:

  • Refer for evidence-based gambling disorder treatment: cognitive behavioral therapy and psychoeducation 5
  • Consider pharmacotherapy targeting gambling disorder specifically (not lithium)
  • Note that gambling disorder is now classified as an addiction disorder, not an impulse control disorder

If bipolar disorder is confirmed:

  • Lithium remains the gold standard for bipolar maintenance treatment 6
  • Ensure adequate therapeutic levels (requires monitoring)
  • Recognize that gambling may improve only if it's secondary to mood episodes

Critical Pitfall to Avoid

Do not continue lithium "just in case" or based on vague diagnostic uncertainty. Lithium requires regular laboratory monitoring, has significant side effects, and carries risks including renal impairment and thyroid dysfunction 1. The WHO guidelines explicitly state lithium should only be initiated "in those settings where personnel and facilities for close clinical and laboratory monitoring are available" 6. Without a clear indication, this burden is unjustified.

The "Dopamine and Serotonin" Hypothesis

Your mention of "lack of dopamine and serotonin" suggests consideration of depression or other neurotransmitter-based disorders. This further supports discontinuing lithium, as it is not a first-line treatment for unipolar depression or primary neurotransmitter deficiency states. If depression is suspected, SSRIs would be more appropriate—but only after establishing the correct primary diagnosis.

Bottom line: Stop the lithium, clarify the diagnosis, and treat what's actually present.

Related Questions

Is lithium or valproate more effective for treating bipolar affective disorder?
What alternative medication can be used for a bipolar patient who has been stable on lithium (lithium carbonate)?
What are the treatment guidelines for Bipolar Disorder?
What are the FDA (United States Food and Drug Administration) approval indications for lithium (lithium carbonate)?
What is the appropriate approach to initiating lithium therapy for bipolar disorder, including necessary baseline labs, dosing schedule, monitoring, and contraindications?
Can lamotrigine (200 mg daily) increase sexual drive or cause sexually oriented behavior in a patient with bipolar II who is also taking bupropion, and how should this be managed?
Is the bipolar diagnosis appropriate for a patient on lamotrigine 200 mg daily and bupropion who has never exhibited grandiosity and is experiencing hypersexuality?
Can you provide a detailed neonatal resuscitation algorithm including timing, medications, and dosages?
What is the appropriate management when end‑tidal carbon dioxide (EtCO₂) is elevated?
What are the indications for initiating emergency hemodialysis in a chronic kidney disease patient, and what is the recommended initial dialysis prescription and temporizing measures?
According to guidelines, when should blood tests be obtained for a patient with chronic kidney disease stage 5, uncontrolled hypertension, anemia with low hemoglobin, iron deficiency and low ferritin, and elevated liver enzymes, blood urea nitrogen, and serum creatinine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.